Below are the financial statements of Eurofins Scientific, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of EUR | 2024 | 2023 |
|---|---|---|
| Revenues | 6,951a | 6,514.6a |
| Operating costs, net | -5,511.6a | -5,280.2a |
| EBITDA | 1,439.4a | 1,234.4a |
| Depreciation and amortisation | -596.9a | -565a |
| EBITAS | 842.5a | 669.4a |
| Share-based payment charge and acquisition-related expenses, net | -138.3a | -137.7a |
| Gain and loss on disposal of subsidiaries, net | -23.6a | -1.8a |
| EBIT | 680.5a | 529.9a |
| Finance income | 24.2a | 22.8a |
| Finance costs | -151.2a | -129.8a |
| Share of profit of associates | 1a | 0.4a |
| Profit before income taxes | 554.6a | 423.3a |
| Income tax expense | -149.1a | -115.5a |
| Net profit for the year | 405.5a | 307.8a |
| Attributable to | — | — |
| Owners of the company and hybrid capital investors | 406.4a | 310.2a |
| Non-controlling interests | -0.9a | -2.5a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eurofins Scientific’s data sources below and access millions more through our Disclosure Search.